181 related items for PubMed ID: 16556157
21. The low-dose dexamethasone suppression test in fibromyalgia.
Wingenfeld K, Wagner D, Schmidt I, Meinlschmidt G, Hellhammer DH, Heim C.
J Psychosom Res; 2007 Jan; 62(1):85-91. PubMed ID: 17188125
[Abstract] [Full Text] [Related]
22. Free and total plasma cortisol measured by immunoassay and mass spectrometry following ACTH₁₋₂₄ stimulation in the assessment of pituitary patients.
Burt MG, Mangelsdorf BL, Rogers A, Ho JT, Lewis JG, Inder WJ, Doogue MP.
J Clin Endocrinol Metab; 2013 May; 98(5):1883-90. PubMed ID: 23539724
[Abstract] [Full Text] [Related]
23. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
Abeyagunawardena AS, Hindmarsh P, Trompeter RS.
Arch Dis Child; 2007 Jul; 92(7):585-8. PubMed ID: 17284479
[Abstract] [Full Text] [Related]
24. Hypothalamic-pituitary-adrenocortical suppression and recovery in renal transplant patients returning to maintenance dialysis.
Rodger RS, Watson MJ, Sellars L, Wilkinson R, Ward MK, Kerr DN.
Q J Med; 1986 Nov; 61(235):1039-46. PubMed ID: 3310063
[Abstract] [Full Text] [Related]
25. Hypothalamic-pituitary-adrenal axis assessment in healthy term neonatal foals utilizing a paired low dose/high dose ACTH stimulation test.
Hart KA, Heusner GL, Norton NA, Barton MH.
J Vet Intern Med; 2009 Nov; 23(2):344-51. PubMed ID: 19192152
[Abstract] [Full Text] [Related]
26. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
Muhtz C, Wester M, Yassouridis A, Wiedemann K, Kellner M.
J Psychiatr Res; 2008 Jul; 42(8):689-93. PubMed ID: 17884095
[Abstract] [Full Text] [Related]
27. Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder.
Ströhle A, Scheel M, Modell S, Holsboer F.
J Psychiatr Res; 2008 Oct; 42(14):1185-8. PubMed ID: 18342888
[Abstract] [Full Text] [Related]
28. Evaluation of the hypothalamic-pituitary-adrenal axis immediately after pituitary adenomectomy: is perioperative steroid therapy necessary?
Hout WM, Arafah BM, Salazar R, Selman W.
J Clin Endocrinol Metab; 1988 Jun; 66(6):1208-12. PubMed ID: 3372683
[Abstract] [Full Text] [Related]
29. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome.
Carneiro G, Togeiro SM, Hayashi LF, Ribeiro-Filho FF, Ribeiro AB, Tufik S, Zanella MT.
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E380-4. PubMed ID: 18523125
[Abstract] [Full Text] [Related]
30. Hypothalamic-pituitary-adrenal axis activity, dehydroepiandrosterone sulphate and their relationships with aggression in early and late alcohol withdrawal.
Ozsoy S, Esel E.
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):340-7. PubMed ID: 17913324
[Abstract] [Full Text] [Related]
31. Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis.
Lizcano F, Salvador J.
Clin Exp Pharmacol Physiol; 2008 Sep 15; 35(9):1085-90. PubMed ID: 18505442
[Abstract] [Full Text] [Related]
32. Intranasal insulin attenuates the hypothalamic-pituitary-adrenal axis response to psychosocial stress.
Bohringer A, Schwabe L, Richter S, Schachinger H.
Psychoneuroendocrinology; 2008 Nov 15; 33(10):1394-400. PubMed ID: 18804330
[Abstract] [Full Text] [Related]
33. Moderate weight loss reduces renin and aldosterone but does not influence basal or stimulated pituitary-adrenal axis function.
Ho JT, Keogh JB, Bornstein SR, Ehrhart-Bornstein M, Lewis JG, Clifton PM, Torpy DJ.
Horm Metab Res; 2007 Sep 15; 39(9):694-9. PubMed ID: 17846979
[Abstract] [Full Text] [Related]
34. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
Van Den Eede F, Moorkens G, Hulstijn W, Van Houdenhove B, Cosyns P, Sabbe BG, Claes SJ.
Psychol Med; 2008 Jul 15; 38(7):963-73. PubMed ID: 17803834
[Abstract] [Full Text] [Related]
35. A hypothetical index of hypothalamic-pituitary-adrenal (HPA) axis function.
Leow MK.
Horm Metab Res; 2005 Jan 15; 37(1):1-3. PubMed ID: 15702430
[Abstract] [Full Text] [Related]
36. Uncoupling of sympathetic nervous system and hypothalamic-pituitary-adrenal axis in cirrhosis.
Wiest R, Moleda L, Zietz B, Hellerbrand C, Schölmerich J, Straub R.
J Gastroenterol Hepatol; 2008 Dec 15; 23(12):1901-8. PubMed ID: 18554237
[Abstract] [Full Text] [Related]
37. Is there any relationship between imatinib mesylate medication and hypothalamic-pituitary-adrenal axis dysfunction?
Bilgir O, Kebapcilar L, Bilgir F, Sarì I, Oner P, Karaca B, Alacacioglu I.
Int J Clin Pract; 2010 Jan 15; 64(1):45-50. PubMed ID: 20089016
[Abstract] [Full Text] [Related]
38. Interpretation of the short Synacthen test in the presence of low cortisol-binding globulin: two case reports.
Moisey R, Wright D, Aye M, Murphy E, Peacey SR.
Ann Clin Biochem; 2006 Sep 15; 43(Pt 5):416-9. PubMed ID: 17022886
[Abstract] [Full Text] [Related]
39. Dysfunction of the hypothalamic-pituitary-adrenal axis in opioid dependent subjects: effects of acute and protracted abstinence.
Zhang GF, Ren YP, Sheng LX, Chi Y, Du WJ, Guo S, Jiang ZN, Xiao L, Luo XN, Tang YL, Smith AK, Liu ZQ, Zhang HX.
Am J Drug Alcohol Abuse; 2008 Sep 15; 34(6):760-8. PubMed ID: 19016181
[Abstract] [Full Text] [Related]
40. The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback.
Raubenheimer PJ, Young EA, Andrew R, Seckl JR.
Clin Endocrinol (Oxf); 2006 Jul 15; 65(1):22-6. PubMed ID: 16817814
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
